Clinical Trials on Lipid Metabolism, Inborn Errors
Total 7151 results
-
ShireCompletedMetachromatic Leukodystrophy (MLD)Australia, Denmark, Japan, France, Germany
-
ShireTerminatedLate Infantile Metachromatic LeukodystrophyDenmark
-
University of PittsburghWithdrawnMetachromatic LeukodystrophyUnited States
-
SanofiActive, not recruitingGaucher's Disease Type III | Gaucher's Disease Type ICanada, Argentina, France, Italy, Japan, Russian Federation, Spain, Sweden, Turkey, United Kingdom
-
ShireTakeda Development Center Americas, Inc.Active, not recruitingMetachromatic Leukodystrophy (MLD)Denmark, Germany, Japan, Australia, France, Brazil, Czechia
-
National Organization for Rare DisordersFood and Drug Administration (FDA)Active, not recruitingMetachromatic LeukodystrophyUnited States
-
Institut National de la Santé Et de la Recherche...Assistance Publique - Hôpitaux de Paris; European Leukodystrophy AssociationActive, not recruitingMetachromatic LeukodystrophyFrance
-
Shenzhen Geno-Immune Medical InstituteUnknown
-
REGENXBIO Inc.WithdrawnLate-infantile Neuronal Ceroid Lipofuscinosis Type 2 (CLN2)
-
BioMarin PharmaceuticalCompletedBatten Disease | CLN2 Disease | Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 | Jansky-Bielschowsky DiseaseUnited States, Italy, Germany, United Kingdom
-
Kastle Therapeutics, LLCIonis Pharmaceuticals, Inc.CompletedCoronary Artery Disease | Heterozygous Familial HypercholesterolemiaUnited States, Canada
-
University Of PerugiaRecruitingObesity | Ketosis | Lysosomal Acid Lipase Deficiency | Ketogenic DietingItaly
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedAmlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)Hypertension | Angina Pectoris | Hypercholesterolemia | Familial Hypercholesterolemia
-
Aga Khan UniversityUnknownKidney Diseases | Anemia | Dyslipidemias | Cardiac Function | Intermittent Fasting | HDL Cholesterol, Low Serum | Hepatic Enzymes and Function AbnormalitiesPakistan
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Coronary Disease | Obesity | Diabetes Mellitus | Hypercholesterolemia, Familial
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedMyocardial Infarction | Myocardial Ischemia | Heart Diseases | Cardiovascular Diseases | Coronary Disease | Hypercholesterolemia, Familial
-
Chelsea and Westminster NHS Foundation TrustUnknownBurns | Critical Illness | Cognitive Impairment | Young Adult | Apolipoprotein E, Deficiency or Defect of
-
University of MiamiHRSA/Maternal and Child Health BureauCompletedPhenylketonuria | Inborn Errors of Metabolism | GalactosemiaUnited States
-
Sciotec Diagnostic Technologies GmbHNot yet recruitingFructose IntoleranceAustria
-
Augusta UniversityUniversity of Iowa; Teikyo UniversityRecruitingFructose IntoleranceUnited States
-
Augusta UniversityUnknownFructose IntoleranceUnited States
-
AceLink Therapeutics, Inc.Tigermed Consulting Co., LtdRecruiting
-
Albina Nowak, MDNot yet recruiting
-
Chiesi Farmaceutici S.p.A.ICON plcRecruiting
-
Children's Hospital Medical Center, CincinnatiSanofiRecruitingFabry DiseaseUnited States
-
University of Sao Paulo General HospitalPfizerRecruiting
-
Genzyme, a Sanofi CompanyRecruitingFabry DiseaseCroatia, United States, Argentina, Australia, Belgium, Bulgaria, Canada, Germany, Hong Kong, India, Indonesia, Korea, Republic of, Kuwait, Malaysia, Philippines, Poland, Romania, Singapore, Slovakia, Taiwan, Thailand, United Kingdom, Vietn... and more
-
ShireTerminatedFabry DiseaseSpain, Greece, Germany, Portugal, Canada, Finland, Poland, Sweden
-
National Human Genome Research Institute (NHGRI)CompletedParkinson Disease | Gaucher DiseaseUnited States
-
Passage Bio, Inc.Active, not recruitingGM1 Gangliosidosis | GM1 Gangliosidosis, Type I | GM1 Gangliosidosis, Type 2 | Beta-Galactosidase-1 (GLB1) DeficiencyUnited States, Canada, United Kingdom, Turkey, Brazil
-
Amicus Therapeutics France SASCompleted
-
Sangamo TherapeuticsActive, not recruitingFabry DiseaseUnited States, United Kingdom, Taiwan, Australia, Germany, Italy, Canada
-
Vastra Gotaland RegionKarolinska University Hospital; Göteborg University; Uppsala University HospitalCompleted
-
4D Molecular TherapeuticsActive, not recruitingFabry DiseaseUnited States
-
Freeline TherapeuticsCompletedLysosomal Storage Diseases | Fabry DiseaseGermany, United Kingdom
-
ProtalixChiesi Farmaceutici S.p.A.CompletedFabry DiseaseUnited States, Serbia, Spain, United Kingdom, Australia, Paraguay
-
AVROBIOTerminatedFabry DiseaseAustralia, Brazil
-
Chiesi Farmaceutici S.p.A.Chiesi USA, Inc.AvailableFabry DiseaseUnited States
-
Massachusetts General HospitalCompleted
-
Idorsia Pharmaceuticals Ltd.CompletedFabry DiseaseUnited States, Spain, Belgium, Australia, Austria, Canada, Germany, Ireland, Italy, Netherlands, Norway, Poland, Switzerland, United Kingdom
-
ShireCompleted
-
ShireCompletedFabry DiseaseUnited States, Slovenia, Australia, Finland, Poland, Czechia, United Kingdom
-
University Hospital MuensterAmicus TherapeuticsCompleted
-
Genzyme, a Sanofi CompanyCompletedFabry DiseaseFrance, Poland, United States, Russian Federation, United Kingdom
-
Amicus TherapeuticsCompletedFabry DiseaseCanada, Belgium, United States, Australia, Netherlands
-
Idorsia Pharmaceuticals Ltd.Completed
-
University Hospital, RouenUnknownAnderson-Fabry DiseaseFrance
-
Zymenex A/SCompletedInfantile Globoid Cell LeukodystrophyUnited States
-
Greenovation Biotech GmbHFGK Clinical Research GmbHCompleted
-
Université de MontréalGenzyme, a Sanofi CompanyCompleted